Alosetron, a 5HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients.

被引:16
作者
Northcutt, AR
Camilleri, M
Mayer, EA
Drossman, DA
Dukes, GE
Ehsanullah, RSB
Hamm, LR
Harding, JP
Heath, AT
Jacques, L
Wolfe, S
Kong, S
McSorley, D
Mangel, AW
机构
[1] Glaxo Wellcome, Res Triangle Pk, NC USA
[2] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
[3] Univ Calif Los Angeles, Sch Med, CURE, Los Angeles, CA USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC USA
关键词
D O I
10.1016/S0016-5085(98)83311-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
G3336
引用
收藏
页码:A812 / A812
页数:1
相关论文
共 1 条
[1]   Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome [J].
Harding, JP ;
Hamm, LR ;
Ehsanullah, RSB ;
Heath, AT ;
Sorrells, SC ;
Haw, J ;
Dukes, GE ;
Wolfe, SG ;
Mangel, AW ;
Northcutt, AR .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) :1073-1076